Screened 2026-09-11 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its accumulation label.
Tetra Tech, Inc. holds its Accumulation at $36.49. The statistical read favours the sellers, held for 10 days.
As held on the ledger · 2026-09-11
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 10 days
Price at the screen
$36.49
Valuation
21.98 trailing · 21.00 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.90
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
23.05%
Below 33%
Interest-bearing debt is just 23.1% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
23.88%
Below 49%
Money owed to the company is 23.9% of assets, under the 49% limit.
Pass
Revenue purity
0.18%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. The price runs 18.3% above the base estimate.
Third-party analyst targets: 6 covering, consensus Buy. The average target sits +10% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Engineering work on water that costs too much today
Picture a company drawing up plans for clean water systems and sustainable builds from California to the Middle East. Tetra Tech delivers steady consulting and engineering, yet the shares trade at a 10 percent premium to our fair value of 28.45 dollars while revenue slips 5 percent. Forward earnings sit at 18.4 times with no visible moat to justify the stretch.
We pass because the numbers show limited room for error. A 26 percent return on equity and 10 percent profit margin look solid on paper, and the ethical screen clears, but a negative margin of safety plus falling top-line growth leave no margin for the usual project delays or contract shifts in this sector.
Analyst price targets sit higher at 40 dollars, yet cyclical infrastructure work often peaks when multiples still look reasonable. Currency moves abroad and government budget cycles add further pressure that the current price does not appear to price in properly. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
TTEK trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-15Markup · changed$34.73+22.2%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 22.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (6 analysts) rates it none, with a mean price target of $41.
2026-07-18Distribution$28.43+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (6 analysts) rates it none, with a mean price target of $41.
2026-07-03Distribution$28.43+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Distribution$28.43Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
